Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 99.34 USD -1.68% Market Closed
Market Cap: $548.4m

Wall St Price Targets

MLAB Price Targets Summary
Mesa Laboratories Inc

Wall Street analysts forecast MLAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MLAB is 114.24 USD with a low forecast of 94.94 USD and a high forecast of 136.5 USD.

Lowest Forecast
Price Target
94.94 USD
4% Downside
Average Forecast
Price Target
114.24 USD
15% Upside
Highest Forecast
Price Target
136.5 USD
37% Upside
Mesa Laboratories Inc Competitors:
Price Targets
EXLS
Exlservice Holdings Inc
24% Upside
NKTX
Nkarta Inc
460% Upside

Revenue
Forecast

14% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
14% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 2 years is 6%.

Gross Profit
Forecast

15% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
15% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 2 years is 6%.

Operating Income
Forecast

5% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
5% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 2 years is 12%.

Pre-Tax Income
Forecast

0% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
0% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 2 years is 30%.

Net Income
Forecast

-1% / Year
Past Growth
49% / Year
Estimated Growth
Estimates Accuracy
-30%
Average Miss
-1% / Year
Past Growth
49% / Year
Estimated Growth
Estimates Accuracy
-30%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 2 years is 49%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MLAB's stock price target?
Price Target
114.24 USD

According to Wall Street analysts, the average 1-year price target for MLAB is 114.24 USD with a low forecast of 94.94 USD and a high forecast of 136.5 USD.

What is the Revenue forecast for Mesa Laboratories Inc?
Projected CAGR
6%

Over the last 14 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 2 years is 6%.

What is the Gross Profit forecast for Mesa Laboratories Inc?
Projected CAGR
6%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 2 years is 6%.

What is the Operating Income forecast for Mesa Laboratories Inc?
Projected CAGR
12%

Over the last 14 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 2 years is 12%.

What is the Pre-Tax Income forecast for Mesa Laboratories Inc?
Projected CAGR
30%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 2 years is 30%.

What is the Net Income forecast for Mesa Laboratories Inc?
Projected CAGR
49%

Over the last 14 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 2 years is 49%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett